Summary for 9MHV
Entry DOI | 10.2210/pdb9mhv/pdb |
Descriptor | Toll-like receptor 7, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (8 entities in total) |
Functional Keywords | toll-like receptor 7, agonist, immune system |
Biological source | Macaca mulatta (Rhesus monkey) |
Total number of polymer chains | 2 |
Total formula weight | 194478.42 |
Authors | |
Primary citation | Poudel, Y.B.,Lo, J.C.,Norris, D.J.,Cox, M.,He, L.,Johnson, W.L.,A M Subbaiah, M.,Mondal, S.,Thangavel, S.,Subramani, L.,Reddy, M.,Jain, S.,Weiss, D.R.,Sivaprakasam, P.,Critton, D.,Mulligan, D.,Xie, C.,Dhar, P.,Li, Y.,Sega, E.,Yamazoe, S.,Gavai, A.V.,Mathur, A.,Zapf, C.W.,Chekler, E.P. Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach. Acs Med.Chem.Lett., 16:80-88, 2025 Cited by PubMed Abstract: Dual activation of the TLR7 and TLR8 pathways leads to the production of type I interferon and proinflammatory cytokines, resulting in efficient antigen presentation by dendritic cells to promote T-cell priming and antitumor immunity. We developed a novel series of TLR7/8 dual agonists with varying ratios of TLR7 and TLR8 activity for use as payloads for an antibody-drug conjugate approach. The agonist-induced production of several cytokines in human whole blood confirmed their functional activity. Structure-activity relationship studies guided by structure-based drug design are described. PubMed: 39811121DOI: 10.1021/acsmedchemlett.4c00463 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.45 Å) |
Structure validation
Download full validation report
